Oppenheimer Asset Management Inc. Has $5.08 Million Holdings in athenahealth, Inc (ATHN)

Oppenheimer Asset Management Inc. boosted its stake in shares of athenahealth, Inc (NASDAQ:ATHN) by 8.8% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 38,028 shares of the health services provider’s stock after purchasing an additional 3,073 shares during the period. Oppenheimer Asset Management Inc. owned approximately 0.09% of athenahealth worth $5,081,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Russell Investments Group Ltd. grew its position in athenahealth by 76.4% during the 3rd quarter. Russell Investments Group Ltd. now owns 22,762 shares of the health services provider’s stock worth $3,041,000 after purchasing an additional 9,860 shares during the period. Alps Advisors Inc. grew its position in athenahealth by 14.3% during the 3rd quarter. Alps Advisors Inc. now owns 4,179 shares of the health services provider’s stock worth $558,000 after purchasing an additional 523 shares during the period. First Trust Advisors LP grew its position in athenahealth by 3.8% during the 3rd quarter. First Trust Advisors LP now owns 118,271 shares of the health services provider’s stock worth $15,801,000 after purchasing an additional 4,356 shares during the period. Strs Ohio grew its position in athenahealth by 69.2% during the 3rd quarter. Strs Ohio now owns 2,217 shares of the health services provider’s stock worth $296,000 after purchasing an additional 907 shares during the period. Finally, Peregrine Capital Management LLC grew its position in athenahealth by 2.7% during the 3rd quarter. Peregrine Capital Management LLC now owns 134,367 shares of the health services provider’s stock worth $17,951,000 after purchasing an additional 3,534 shares during the period.

Several equities research analysts have weighed in on ATHN shares. Royal Bank of Canada reaffirmed a “hold” rating and set a $140.00 price target on shares of athenahealth in a research report on Friday, September 28th. BidaskClub lowered shares of athenahealth from a “sell” rating to a “strong sell” rating in a research note on Friday, August 10th. MED lowered their target price on shares of athenahealth to $140.00 and set a “hold” rating on the stock in a research note on Wednesday, September 19th. SunTrust Banks lowered their target price on shares of athenahealth to $150.00 in a research note on Wednesday, September 19th. Finally, Leerink Swann set a $140.00 target price on shares of athenahealth and gave the stock a “buy” rating in a research note on Friday, September 28th. One investment analyst has rated the stock with a sell rating, thirteen have issued a hold rating and seven have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $153.89.



In related news, insider Daniel P. Haley sold 2,204 shares of the firm’s stock in a transaction dated Monday, October 1st. The shares were sold at an average price of $127.23, for a total value of $280,414.92. Following the transaction, the insider now directly owns 10,555 shares of the company’s stock, valued at approximately $1,342,912.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders sold a total of 2,654 shares of company stock worth $340,770 over the last ninety days. 2.90% of the stock is currently owned by corporate insiders.

Shares of athenahealth stock opened at $123.50 on Monday. The stock has a market capitalization of $5.00 billion, a P/E ratio of 78.66, a P/E/G ratio of 2.18 and a beta of 0.97. athenahealth, Inc has a twelve month low of $116.77 and a twelve month high of $163.94. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.62 and a current ratio of 2.62.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Monday, July 30th. The health services provider reported $1.09 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.47. The firm had revenue of $323.30 million for the quarter, compared to analyst estimates of $334.77 million. athenahealth had a net margin of 8.71% and a return on equity of 14.71%. athenahealth’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the company posted $0.51 EPS. Sell-side analysts forecast that athenahealth, Inc will post 3.22 EPS for the current year.

About athenahealth

athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.

Recommended Story: Fundamental Analysis and Individual Investors

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply